xTAG
Applied Biocode intends to have panel for identifying 18 gastrointestinal pathogens on the clinical market by the end of the year.
Luminex Q3 Revenues Jump 12 Percent on Assay Sales
NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories.
NEW YORK (GenomeWeb) – Luminex last week provided an update on nxTAG, its next-generation multiplexing technology in development, pledging a "seamless upgrade" for existing customers of its xTAG bead array products, and promising to have nxTAG in customers' hands by sometime next year.
NEW YORK (GenomeWeb) — Luminex executives this week provided investors with an update on the progress of Aries, the sample-to-answer molecular testing platform that the company plans to launch in Europe later this year and the US next year.
Luminex Provides Updates on xTAG Test Sales, US Reimbursement Environment, New Multiplexing Tech
Premium
NEW YORK (GenomeWeb) – Luminex said this week that double-digit growth in sales of its xTAG Respiratory Viral and Gastrointestinal Pathogen Panels contributed to an increase in first quarter revenues.
Nov 19, 2013
Nov 4, 2013
Irori Sues Luminex for Patent Infringement
May 2, 2013
Dec 13, 2012
Jul 12, 2012